An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...

The fund counts among its backers the family office of Silver Lake’s Mike Bingle, Manipal Group’s Ranjan Pai, Bharat Serums’ ...

Looking ahead, we believe key programs in our R&D portfolio offer significant opportunities to help address substantial patient needs and drive Pfizer's growth in the coming years. I will mention some ...

Biotech giant Bristol-Myers Squibb Company BMY is scheduled to report fourth-quarter and full-year 2025 results on Feb. 5, ...

Bristol Myers Squibb Co. forecast 2026 sales and profit above Wall Street’s expectations, a sign that the company’s newer ...

Pharmaceutical giant Pfizer (PFE) released its fourth quarter earnings results that topped Wall Street's expectations on its ...

PE fund 108 Bio Capital backs Pinwheel Therapeutics, commits $20 million for phase2b trial: Our Bureau, Bengaluru Thursday, February 5, 2026, 12:30 Hrs [IST] Pinwheel Therapeutics ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Some Kansas pharmacies will close Wednesday to advocate for legislation aimed at increasing transparency in prescription drug ...

With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the ...